Eric Kaldjian,
Chief Medical Officer
Eric is Chief Medical Officer of RareCyte, directing scientific and medical applications of its rare cell detection technology. Before joining RareCyte he was Medical Director for Companion Diagnostics at Ventana Medical Systems/Roche. His pharmaceutical experience at Hoffmann-La Roche and at Parke-Davis/Pfizer encompassed discovery research through full clinical development positions with a focus on translational medicine. He was Chief Scientific Officer at Transgenomic and directed clinical genomics programs at Gene Logic. He received his anatomic pathology training at the University of Michigan and was a hematopathology/immunology fellow at the National Cancer Institute. He is an associate member of the BioInterfaces Institute at the University of Michigan.
|
|
|
